Patients' perspectives on the relevance of biosimilars' outcomes in oncology: qualitative study with nominal group technique.

Patients rated most outcomes as critical or important, some of them previously regarded as secondary by the researchers, which reinforces the need to include stakeholders' perspectives in oncology research. Aspects of the disease progression and treatment effects influenced participants' judgment on outcomes' relevance.